RNA Smart Money
Atrium Therapeutics, Inc.
1W: -5.4%
1M: -44.2%
3M: -39.7%
YTD: -89.1%
1Y: -82.0%
3Y: +22.9%
5Y: -67.7%
$7.84
-0.30 (-3.69%)
Weekly Expected Move ±11.5%
$6
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026200
Institutions Holding
+39 vs prior
130.4%
Ownership
-2.04%
42
New
46
Increased
80
Reduced
45
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Boyce Sarah | director | F-Tax Withholding | 126,418 | $8.95 | $1.1M | Filing |
| 2026-09-18 | Flanagan W. Michael | director | F-Tax Withholding | 22,812 | $8.95 | $204K | Filing |
| 2026-09-18 | Hughes Steven George | officer: chief medical officer | F-Tax Withholding | 21,459 | $8.95 | $192K | Filing |
| 2026-09-18 | Younis Husam | officer: chief scientific officer | F-Tax Withholding | 11,216 | $8.95 | $100K | Filing |
| 2026-04-20 | Winslow Brendan R. | officer: chief financial officer | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-04-20 | Hughes Steven George | officer: chief medical officer | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-04-20 | Kenney Stephanie | officer: see remarks | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-04-20 | Younis Husam | officer: chief scientific officer | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-04-20 | Hoyos Rocio Martin | officer: chief strategy officer | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-04-20 | Gallagher Kathleen P. | officer: see remarks | A-Grant/Award | 102,500 | $— | $0 | Filing |
| 2026-01-21 | Boyce Sarah | officer: president and ceo | S-Sale | 7,993 | $72.45 | $579K | Filing |
| 2026-01-21 | Boyce Sarah | officer: president and ceo | S-Sale | 6,394 | $72.45 | $463K | Filing |
| 2026-01-21 | Hughes Steven George | officer: chief medical officer | S-Sale | 2,017 | $72.45 | $146K | Filing |
| 2026-01-21 | Hughes Steven George | officer: chief medical officer | S-Sale | 2,878 | $72.45 | $209K | Filing |
| 2026-01-21 | Flanagan W. Michael | officer: chief scientific officer | S-Sale | 2,558 | $72.45 | $185K | Filing |
| 2026-01-21 | Flanagan W. Michael | officer: chief scientific officer | S-Sale | 3,976 | $72.45 | $288K | Filing |
| 2026-01-21 | MacLean Michael F | officer: chief financial officer | S-Sale | 2,735 | $72.45 | $198K | Filing |
| 2026-01-21 | MacLean Michael F | officer: chief financial officer | S-Sale | 1,807 | $72.45 | $131K | Filing |
| 2026-01-21 | LEVIN ARTHUR A | director | S-Sale | 1,758 | $72.45 | $127K | Filing |
| 2026-01-21 | McCarthy Teresa | officer: chief human resources officer | S-Sale | 1,453 | $72.45 | $105K | Filing |
| 2026-01-21 | McCarthy Teresa | officer: chief human resources officer | S-Sale | 1,476 | $72.45 | $107K | Filing |
| 2026-01-07 | McCarthy Teresa | officer: chief human resources officer | S-Sale | 1,965 | $72.23 | $142K | Filing |
| 2026-01-07 | Calderaro Charles III | officer: chief technical officer | S-Sale | 3,727 | $72.23 | $269K | Filing |
| 2026-01-07 | Hughes Steven George | officer: chief medical officer | S-Sale | 2,373 | $72.23 | $171K | Filing |
| 2026-01-07 | Flanagan W. Michael | officer: chief scientific officer | S-Sale | 2,373 | $72.23 | $171K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Sessa Capital IM, L.P. | 1,500,000 | $20M | +948,609 | 2026-06-30 | Filing |
| BlackRock, Inc. | 1,447,476 | $19M | +242,185 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 730,831 | $10M | +103,962 | 2026-06-30 | Filing |
| CRCM LP | 641,539 | $9M | +641,539 | 2026-06-30 | Filing |
| TIG Advisors, LLC | 561,533 | $8M | -46,019 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 386,929 | $5M | +67,098 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 345,481 | $5M | +166,921 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 310,341 | $4M | -39,609 | 2026-06-30 | Filing |
| 683 Capital Management, LLC | 300,000 | $4M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 271,762 | $4M | +14,676 | 2026-06-30 | Filing |
| Arbiter Partners Capital Management LLC | 261,288 | $4M | +31,288 | 2026-06-30 | Filing |
| CANTOR FITZGERALD, L. P. | 256,917 | $3M | +21,280 | 2026-06-30 | Filing |
| Slotnik Capital, LLC | 237,637 | $3M | +56,692 | 2026-06-30 | Filing |
| Weiss Asset Management LP | 219,730 | $3M | -20,971 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 200,559 | $3M | +9,700 | 2026-06-30 | Filing |
| Schonfeld Strategic Advisors LLC | 199,158 | $3M | +36,399 | 2026-06-30 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 172,235 | $2M | +172,235 | 2026-06-30 | Filing |
| NEXPOINT ASSET MANAGEMENT, L.P. | 150,025 | $2M | — | 2026-06-30 | Filing |
| Polar Asset Management Partners Inc. | 150,000 | $2M | +80,000 | 2026-06-30 | Filing |
| Squarepoint Ops LLC | 146,743 | $2M | -84,723 | 2026-06-30 | Filing |